Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q3 FY23 Earnings Presentation
26 slides from Apollo Hospitals Enterprise's earnings presentation, Feb 14, 2023
Slide 1: Regulation 30 disclosure letter to stock exchanges
APOLLO HOSPITALS ENTERPRISE LIMITED CIN :L85110TN1979PLC008035 14 February 2023 The Secretary, Bombay Stock Exchange Ltd (BSE) Phiroze Jnheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 508869 ISIN INE437A01024 Dear Sir, The Secretary, National Stock Exchange, Exchange Plaza, 5th Flo
Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q3 FY23
APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q3 FY23
Slide 3: Key Highlights
Key Highlights Highlights Financials Healthcare Services Diagnostics & Retail Digital Health Annexure Health & Pharmacy Distribution 2
Slide 4: Highlights
HIGHLIGHTS 3
Slide 5: Highlights Q3FY23
Highlights Q3FY23 Healthcare Revenue EBITDA Services 43 Owned 9,385 65% INR 51,482 / ` 21,944 Mio ` 5,428 Mio (Hospitals) 136,992 + Owned & Occupancy day Rev In-patients 52% 24.7% Share 5 Managed Managed ARPOB1 Margin Hospitals Beds ` 3,114 Mio ` 255 Mio Diagnostics & Rev 7% 8.2% Share Retail Health
Slide 6: Highlights Q3FY23
Highlights Q3FY23 o Consolidated Revenues at `42,636 Mio for Q3FY23 growth of 19% yoy excluding vaccination revenue in Q3FY22. o Consolidated EBITDA before 247 operating cost of `7,078 Mio Financial o 247 costs at `2,024 Mio including Non Cash ESOP Charge of `280 Mio. Performance o Consolidated PAT
Slide 7: Financials Consolidated
Financials Consolidated 6
Slide 8: Consolidated Financials Q3 FY23
Consolidated Financials Q3 FY23 Digital Health Healthcare Diagnostics & ` Mio & Pharmacy Consol Gross Debt 24,559 Services Retail Health Distribution Total Revenues 21,944 3,114 17,578 42,636 Cash & Cash 11,340 EBITDA (Post Ind AS 116) (Pre 24|7 Cost) 5,428 255 1,395 7,078 Equivalents1 margin (%) 24
Slide 9: Consolidated Financials YTD Dec 22
Consolidated Financials YTD Dec 22 (` mio) Digital Health & Healthcare Diagnostics & ` Mio Pharmacy Consol Services Retail Health Distribution Note 1 : Total Revenues 64,823 9,227 49,053 123,103 Covid Vaccination revenues in YTD Dec21 EBITDA (Post Ind AS 116) (Pre 24|7 Cost) 15,984 926 3,885 20,795
Slide 10: Healthcare Services
Healthcare Services Hospitals Consolidated 9
Slide 11: Consolidated Healthcare Services Performance Q3FY23
Consolidated Healthcare Services Performance Q3FY23 Healthcare Serv Healthcare Serv Healthcare Serv Group (New & Volume grew by 7% from 127,441 in Q3FY22 to Group (Mature) Group Others) 136,992 in Q3FY23. No of Hospitals 29 14 43 Operating beds 5471 2384 7855 Revenue grew by 10% excluding covid vacc
Slide 12: Consolidated Healthcare Services Performance YTD Dec22
Consolidated Healthcare Services Performance YTD Dec22 Healthcare Serv Healthcare Serv Healthcare Serv Group (New & Volume grew by 18% from 344,250 in YTD Dec 21 Group (Mature) Group Others) to 406,890 in YTD Dec 22 No of Hospitals 29 14 43 Operating beds 5471 2384 7855 Revenue grew by 12%YoY exclud
Slide 13: Region wise Operational Parameters
Region wise Operational Parameters Tamilnadu Region AP, Telengana Region (Hyderabad Total (6) (2) (Chennai & others) (1) & others) Particulars YTD Dec 21 YTD Dec 22 yoy (%) YTD Dec 21 YTD Dec 22 yoy (%) YTD Dec 21 YTD Dec 22 yoy (%) YTD Dec 22 ARPOB in Metro cities No. of Operating beds 7,860 7,855
Slide 14: Diagnostics & Retail Health
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd 13
Slide 15: Executive Summary
Executive Summary ➢ Network grew by 33% in YTD FY23 from 468 touchpoints in FY22 to 621 touchpoints in YTD FY23 Primary ➢ Health checks and Consultations volumes grew by 33% and 40% respectively YoY Care ➢ Focus on expanding network to take care closer to communities ➢ Diagnostics business added 330
Slide 16: Financial Performance Q3FY23
Financial Performance Q3FY23 (` mio) Q3 FY23 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 341 1,570 55 114 111 10 17 11 AHLL reported a revenue drop in Q3 Footfalls/Day* 2,819 11,506 457 190 1,718 52 31 73 FY23 on YoY basis due to decline of Gross ARPP (Rs.)* 1,842
Slide 17: Financial Performance YTD Dec 22
Financial Performance YTD Dec 22 (` mio) YTD Dec 22 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) AHLL reported a revenue drop in YTD FY23 on Network 341 1,570 55 114 111 10 17 11 YoY basis due to decline of Covid Vaccination Footfalls/Day* 3,278 12,069 478 205 1,614 47 32
Slide 18: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn)1 Operational footprint EBITDA* (INR Mn)2 (as of Dec 31, 2022) 1,087 1,040 922 940 ~200 816 118 18% Cities presence 413 24 99 14% in India 358 12% 922 916 162 152 717 129 564 675 3% 3%# 95 22 31 Labs Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q3 FY22*
Slide 19: Digital Health & Pharmacy Distribution
Digital Health & Pharmacy Distribution Apollo Health Co 18
Slide 20: India's Largest Omni-Channel Healthcare
India’s Largest Omni-Channel Healthcare Apollo HealthCo Ltd (AHL) Apollo 247 –Digital Platform Apollo Pharmacy Platform Added As at December 31, 2022 757 YTD 23 ~23Mn+ ~7 Lakh+ ~6,300+ Closed 90 Registrations Daily Active Users Doctors YTD 23 Chandigarh: 6 Net 667 Virtual Doctor Consultation Daily C
Slide 21: Health Co Financials Q3 FY23
Health Co Financials Q3 FY23 Online Pharmacy Offline Pharmacy Total Health ` Mio Distribution & o Q3 delivered GMV : Rs 543 cr (85% higher from Q2 FY23). Distribution Co Apollo 247 New business opportunities created around consultation - Total Revenues 15,811 1,767 17,578 Hospital IP&OP contributing
Slide 22: Health Co Financials YTD Dec 22
Health Co Financials YTD Dec 22 Online Pharmacy Offline Pharmacy Total Health ` Mio Distribution & Distribution Co o Digital platform delivered GMV : Rs 1,052 cr (YTD Dec 22) Apollo 247 Total Revenues 44,499 4,554 49,053 o Combined Pharmacy platform business reported revenue of EBITDA (Post Ind AS 1
Slide 23: Annexure
Annexure 22
Slide 24: Basis of Consolidation
Basis of Consolidation AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description AHEL Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services Platform 100.00% Tondiarpet - Chennai Chennai A
Slide 25: Ind AS 116: Impact on P&L and Balance Sheet
` Mio IND AS - 116 : Impact on P&L and Balance Sheet – YTD Dec 22 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 5,426 Revenue Right of use 11,750 Revenue Asset Asset Other 620 Other as of as of 1,445 expense
Slide 26: Thank you!
SS Wi Thank you!
Apollo Hospitals Enterprise — Q3 FY23 Earnings Presentation on 6ix